MedTrace Logo

Online Aerobic Exercise and Quality of Life in Non-diagnosed COVID-19 Adults

NCT06517771 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2024-11-20

No results posted yet for this study

Summary

During the new coronavirus-19 (COVID-19) pandemic, assessing the effects of online aerobic exercise on physical performance and health-related quality of life (HRQoL) in adults has garnered significant interest. This study, which investigated the impact of four-week online aerobic exercise on physical performance and HRQoL in non-diagnosed COVID-19 adults, provides crucial insights. After the study was completed, the four-week online exercise program did not significantly enhance physical performance and HRQoL but increased physical activity. These findings are important for understanding the potential of online aerobic exercise. While it may not yield notable health-related benefits, it can boost physical activity in non-diagnosed COVID-19 adults.

Conditions

  • Exercise

Interventions

OTHER

Online aerobic exercise

Before starting the online aerobic exercises, for general warm-up, two minutes of walking, one minute of marching, and ten repetitions of bilateral reciprocal shoulder flexion-extension, shoulder horizontal abduction-adduction, and unilateral shoulder flexion and circling exercises were performed. For the upper extremity, full elbow extension with shoulder retraction in full shoulder flexion (Exercise V), elbows 90 degrees flexion with shoulder retraction in 90 degrees abduction (Exercise U), and full elbow flexion with shoulder extension of about 30 degrees (Exercise W) were performed. Standing hip abduction-extension, elevation on tiptoe, standing-sitting from a chair with hands on shoulders, squatting, tandem walking, and standing on one leg exercises were performed in the lower extremities. Gastrocnemius, hamstring, and shoulder posterior and inferior capsule stretching exercises were conducted as cooling exercises.

Sponsors & Collaborators

  • Muş Alparslan University

    lead OTHER

Principal Investigators

  • Gökhan Bayrak, PhD · Muş Alparslan University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2023-07-01
Completion
2023-07-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06517771 on ClinicalTrials.gov